Amedica Announces Launch of New Facet Joint Implant New Product Called Procet™ Expands Facet Product Portfolio to Treat Spinal Stenosis
SALT LAKE CITY, March 6, 2012 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer, focused on proprietary silicon nitride (Si3N4) ceramic technologies, announced today the launch of a new spinal implant called Procet™. Procet has been designed to treat patients who suffer from low back pain, caused by spinal stenosis.
The Procet Facet Allograft Implant system has a dual-hemispherical shape that limits motion while providing distraction; and unlike other products currently available, it is designed to remain stable in the joint, to increase the potential for fusion. This procedure provides surgeons a percutaneous, less invasive, early-stage treatment, which is particularly beneficial to elderly patients for whom more extensive open surgery may present too great a surgical risk.
Eric K. Olson, President and Chief Executive Officer, said, "The launch of the Procet system is an example of Amedica's commitment to further expand our line of innovative facet products to support our surgeon customers and the patients they treat. Procet, in addition to our other facet products, showcases our company's strength in developing state-of-the-art, minimally invasive medical products."
Mr. Olson added, "This launch is also consistent with our strategy to increase sales of proprietary, IP-backed innovative products, which should drive improved gross margins and profitability."
The Procet Facet Allograft Implants add to Amedica's existing Facet Fixation System™ portfolio which includes the Javelin® MIS Facet Screw System and FacetGun® Max System.
Additional information about the Company's complete line of products may be found at www.amedica.com.
About Amedica Corporation:
Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy. Amedica is a privately held, private equity backed ceramic manufacturing and implant distribution company founded in 1996 by internationally recognized Orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and are sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.
SOURCE Amedica Corporation